We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Qardus is an ethical and Sharia-compliant financing platform for social impact Small and Medium Enterprises (SMEs) and investors. Qardus asserts that the 3.8 million Muslim community in the UK, and 25 million in Europe, is massively underserved when it comes to accessing interest-free (Sharia-compliant) structures. It intends to change this. Qardus offers up to £200,000 in innovative interest-free business financing to eligible SMEs for tenors of up to 24 months and is Financial Conduct Authority (FCA) approved. Qardus points out that it has provided over £250,000 in financing to some high social impact SMEs during the COVID-19 pandemic, maintained a 100% track record with a 0% default rate to date, and featured in media entities like Sifted, Islamic Finance News, Peer-to-Peer Finance News, and Fintech Futures amongst others. It will use 30% of the investment on marketing costs for acquiring SMEs and investors on its platform, 60% on growing its team, and 10% on obtaining additional licenses to expand its services.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £313,009
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
Loowatt is delivering safe sanitation and generating energy from waste for sustainable business growth. Loowatt argues that poor sanitation leads to more than £150 billion being lost every year due to health care costs, decreased income and productivity. It aims to change this with its patented toilet. The toilet's waterless flush seals waste hygienically away and is the starting point for Loowatt's unique closed-loop processing system. Loowatt works closely with the local utility partners and ensures that waste is safely collected, treated, and transformed into biogas to generate electricity and heat with nutrients captured for organic fertiliser production. Loowatt has processed 555 tonnes of waste and served more than 250,000 people. The company will use the investment to scale-up manufacturing, complete development of the Loowatt Pro data transmission system, and develop an aftersales monetisation strategy for large international contracts, starting with the City of Manila.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,101,180
An artificially intelligent web-based app for stock market investors to potentially increase their returns. Butterwire's platform aims to solve three common challenges more than 1 million UK investors face: finding high-return opportunities, minimising risk and being aware of sudden market fluctuations.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph